Lucid Diagnostics (LUCD) Operating Expenses (2020 - 2026)

Lucid Diagnostics has reported Operating Expenses for 7 years, with the latest figure at $13.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses changed 0.41% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $54.4 million (up 4.78% YoY), and the FY2025 full-year result was $54.3 million, up 7.83% from the prior year.
• Operating Expenses for Q1 2026 stood at $13.4 million, down from $15.5 million in the prior quarter.
• The five-year high for Operating Expenses was $15.5 million in Q4 2025, with the low at $11.7 million in Q2 2023.
• Historically, Operating Expenses has averaged $13.3 million across 5 years, with a median of $13.0 million in 2025.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 241.09% — and 2024, when it dropped 20.12%.
• Lucid Diagnostics' Operating Expenses stood at $15.1 million in 2022, then decreased by 17.19% to $12.5 million in 2023, then grew by 8.64% to $13.6 million in 2024, then advanced by 14.32% to $15.5 million in 2025, then fell by 13.83% to $13.4 million in 2026.
• The last three Operating Expenses figures came in at $13.4 million (Q1 2026), $15.5 million (Q4 2025), and $13.0 million (Q3 2025), per Business Quant data.